290 related articles for article (PubMed ID: 33462873)
1. Platinum accumulation in oxaliplatin-induced peripheral neuropathy.
Wei G; Gu Z; Gu J; Yu J; Huang X; Qin F; Li L; Ding R; Huo J
J Peripher Nerv Syst; 2021 Mar; 26(1):35-42. PubMed ID: 33462873
[TBL] [Abstract][Full Text] [Related]
2. Identification of drug transporters contributing to oxaliplatin-induced peripheral neuropathy.
Fujita S; Hirota T; Sakiyama R; Baba M; Ieiri I
J Neurochem; 2019 Feb; 148(3):373-385. PubMed ID: 30295925
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of effects of copper histidine on copper transporter 1-mediated accumulation of platinum and oxaliplatin-induced neurotoxicity in vitro and in vivo.
Ip V; Liu JJ; McKeage MJ
Clin Exp Pharmacol Physiol; 2013 Jun; 40(6):371-8. PubMed ID: 23556474
[TBL] [Abstract][Full Text] [Related]
4. L-tetrahydropalmatine reduces oxaliplatin accumulation in the dorsal root ganglion and mitochondria through selectively inhibiting the transporter-mediated uptake thereby attenuates peripheral neurotoxicity.
Yi Y; Li L; Song F; Li P; Chen M; Ni S; Zhang H; Zhou H; Zeng S; Jiang H
Toxicology; 2021 Jul; 459():152853. PubMed ID: 34252480
[TBL] [Abstract][Full Text] [Related]
5. Danggui Sini decoction protects against oxaliplatin-induced peripheral neuropathy in rats.
Ding R; Wang Y; Zhu JP; Lu WG; Wei GL; Gu ZC; An ZT; Huo JG
J Integr Neurosci; 2020 Dec; 19(4):663-671. PubMed ID: 33378840
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function.
Yang Y; Luo L; Cai X; Fang Y; Wang J; Chen G; Yang J; Zhou Q; Sun X; Cheng X; Yan H; Lu W; Hu C; Cao P
Free Radic Biol Med; 2018 May; 120():13-24. PubMed ID: 29530794
[TBL] [Abstract][Full Text] [Related]
7. Metformin reduces c-Fos and ATF3 expression in the dorsal root ganglia and protects against oxaliplatin-induced peripheral sensory neuropathy in mice.
Pereira AF; Pereira LMS; Silva CMP; Freitas Alves BW; Barbosa JS; Pinto FMM; Pereira AC; Silva KO; Pontes RB; Alencar NMN; Lima-Júnior RCP; Vale ML
Neurosci Lett; 2019 Sep; 709():134378. PubMed ID: 31325582
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-toxicodynamic Modeling to Elucidate the Involvement of Dorsal Root Ganglion Neuron in Oxaliplatin-induced Peripheral Neuropathy.
Tsukushi Y; Kobuchi S; Ito Y; Sakaeda T
Anticancer Res; 2024 Feb; 44(2):575-584. PubMed ID: 38307592
[TBL] [Abstract][Full Text] [Related]
10. The role of oxidative stress and anti-oxidant treatment in platinum-induced peripheral neurotoxicity.
Carozzi VA; Marmiroli P; Cavaletti G
Curr Cancer Drug Targets; 2010 Nov; 10(7):670-82. PubMed ID: 20578989
[TBL] [Abstract][Full Text] [Related]
11. Based on Systematic Pharmacology: Molecular Mechanism of Siwei Jianbu Decoction in Preventing Oxaliplatin-Induced Peripheral Neuropathy.
Zhang P; Lu Y; Yang C; Zhang Q; Qian Y; Suo J; Cheng P; Zhu J
Neural Plast; 2020; 2020():8880543. PubMed ID: 33082779
[TBL] [Abstract][Full Text] [Related]
12. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2.
Sprowl JA; Ciarimboli G; Lancaster CS; Giovinazzo H; Gibson AA; Du G; Janke LJ; Cavaletti G; Shields AF; Sparreboom A
Proc Natl Acad Sci U S A; 2013 Jul; 110(27):11199-204. PubMed ID: 23776246
[TBL] [Abstract][Full Text] [Related]
14. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice.
Ta LE; Bieber AJ; Carlton SM; Loprinzi CL; Low PA; Windebank AJ
Mol Pain; 2010 Mar; 6():15. PubMed ID: 20205720
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of ATP7A, ATP7B and CTR1 in adult rat dorsal root ganglion tissue.
Ip V; Liu JJ; Mercer JF; McKeage MJ
Mol Pain; 2010 Sep; 6():53. PubMed ID: 20836889
[TBL] [Abstract][Full Text] [Related]
16. Oxaliplatin rechallenge in metastatic colorectal cancer patients with clinically significant oxaliplatin-induced peripheral neurotoxicity.
Argyriou AA; Kalofonou F; Litsardopoulos P; Anastopoulou GG; Kalofonos HP
J Peripher Nerv Syst; 2021 Mar; 26(1):43-48. PubMed ID: 33345432
[TBL] [Abstract][Full Text] [Related]
17. Skin platinum deposition in colorectal cancer patients following oxaliplatin-based therapy.
Cao Y; Chang Q; Zhang W; Ornatsky O; Hedley D; Chen EX
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1195-1200. PubMed ID: 31520102
[TBL] [Abstract][Full Text] [Related]
18. Metabolomics analysis reveals characteristic metabolites in different levels of oxaliplatin-induced neurotoxicity.
Hua Y; Wang R; Liu Y; Liu Q; Qi X; Ding Y; Lv J
J Sep Sci; 2024 Jun; 47(11):e2400164. PubMed ID: 38819794
[TBL] [Abstract][Full Text] [Related]
19. Rosmarinic Acid Mitigates Mitochondrial Dysfunction and Spinal Glial Activation in Oxaliplatin-induced Peripheral Neuropathy.
Areti A; Komirishetty P; Kalvala AK; Nellaiappan K; Kumar A
Mol Neurobiol; 2018 Sep; 55(9):7463-7475. PubMed ID: 29427084
[TBL] [Abstract][Full Text] [Related]
20. Ergothioneine ameliorates oxaliplatin-induced peripheral neuropathy in rats.
Nishida K; Takeuchi K; Hosoda A; Sugano S; Morisaki E; Ohishi A; Nagasawa K
Life Sci; 2018 Aug; 207():516-524. PubMed ID: 29981320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
